Rye Dalton

Rye Dalton is an experienced professional in commercial analytics and operations, currently serving as the VP of Commercial Analytics and Operations at Neurocrine Biosciences since February 2024. Previously, Rye worked at Acacia Pharma Inc. from April 2018 to March 2024, holding the positions of Senior Vice President and Vice President of Commercial Analytics and Operations. Other notable roles include Vice President of Commercial Operations at Otonomy, Inc., and Sr. Director of Commercial Operations at Cadence Pharmaceuticals. Rye's career began at Dura Pharmaceuticals and Elan, where key contributions were made in sales operations. Academic credentials include an MBA from Ohio University, completed in 2021, and a BA in Political Science and Economics from the University of Cincinnati, earned in 1993.